News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Egetis to participate at upcoming investor conferences

November 21, 2022

Stockholm, Sweden, November 21, 2022. Egetis Therapeutics AB (publ) (Nasdaq Stockholm: EGTX) today announced that the Company will participate at the following upcoming investor conferences and events:
SEB Annual Healthcare Seminar
November 21, 2022, Stockholm

Redeye Life Science Summit
November 24, 2022, Stockholm

Erik Penser Bank Temadag – Healthcare
December 1, 2022, Stockholm

DNB Nordic Healthcare Conference
December 15, 2022, Oslo

JP Morgan Annual Healthcare Conference
January 9-12, 2023, San Francisco



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10